RAI(ShcC N-Shc)-dependent recruitment of GAB1 to RET oncoproteins potentiates PI3-K signalling in thyroid tumors

• Published in: Oncogene Vol. 24; no. 41; pp. 6303 - 6313
• Main Authors: DE FALCO, Valentina, GUARINO, Valentina, MALORNI, Luca, CIRAFICI, Anna Maria, TROGLIO, Flavia, ERRENI, Marco, PELICCI, Giuliana, SANTORO, Massimo, MELILLO, Rosa Marina
• Format: Journal Article
• Language: English
• Published: Basingstoke Nature Publishing 15.09.2005; Nature Publishing Group
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Apoptosis; Biological and medical sciences; Cell physiology; Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes; Ectopic expression; Fundamental and applied biological sciences. Psychology; Grb2 protein; Kinases; Ligands; Molecular and cellular biology; Mutation; Oncology; Oncoproteins; Phosphorylation; Protein-tyrosine kinase receptors; Proteins; Recruitment; Ret protein; Signal transduction; Stoichiometry; Thyroid cancer; Thyroid carcinoma; Tumor cell lines; Tumors; C-Onc gene; Tumor; RET oncogenes; RAI and GAB1 adaptors; Onc gene; Carcinogenesis; thyroid tumor
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/sj.onc.1208776

RAI, also named ShcC/N-Shc, one of the members of the Shc proteins family, is a substrate of the RET receptor tyrosine kinase. Here, we show that RAI forms a protein complex with both RET/MEN 2 A and RET/PTC oncoproteins. By co-immunoprecipitation, we found that RAI associates with the Grb 2-associated binder 1 (GAB 1) adapter. This association is constitutive, but, in the presence of RET oncoproteins, both RAI and GAB 1 are tyrosine-phosphorylated, and the stoichiometry of this interaction remarkably increases. Consequently, the p 85 regulatory subunit of phosphatidylinositol-3 kinase (PI-3 K) is recruited to the complex, and its downstream effector Akt is activated. We show that human thyroid cancer cell lines derived from papillary or medullary thyroid carcinoma (PTC or MTC) carrying, respectively, RET/PTC and RET/MEN 2 A oncoproteins express RAI proteins. We also show that human PTC samples express higher levels of RAI, when compared to normal thyroid tissue. In thyroid cells expressing RET/PTC 1, ectopic expression of RAI protects cells from apoptosis; on the other hand, the silencing of endogenous RAI by small inhibitory duplex RNAs in a PTC cell line that expresses endogenous RET/PTC 1, increases the rate of spontaneous apoptosis. These data suggest that RAI is a critical substrate for RET oncoproteins in thyroid carcinomas.